Unknown

Dataset Information

0

Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2.

ABSTRACT:

SUBMITTER: Jiang S 

PROVIDER: S-EPMC7544964 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2.

Jiang Shibo S   Zhang Xiujuan X   Du Lanying L  

Expert opinion on therapeutic targets 20200917 6

Similar Datasets

Unknown Neutralizing antibodies targeting SARS-CoV-2 spike protein.
| S-EPMC7737530 | biostudies-literature
Unknown Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein.
| S-EPMC8353886 | biostudies-literature
Unknown Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.
| S-EPMC8609008 | biostudies-literature
Unknown Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides.
| S-EPMC8128053 | biostudies-literature
Unknown A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
| S-EPMC7803729 | biostudies-literature
Unknown Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.
| S-EPMC8074524 | biostudies-literature
Unknown Entry Inhibitors of SARS-CoV-2 Targeting the Transmembrane Domain of the Spike Protein.
| S-EPMC12300635 | biostudies-literature
Unknown Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.
| S-EPMC8264305 | biostudies-literature
Unknown Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies.
| S-EPMC8079265 | biostudies-literature
Unknown Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential.
| S-EPMC8444149 | biostudies-literature